Psychosis News and Research

RSS

Psychosis means abnormal condition of the mind, and is a generic psychiatric term for a mental state often described as involving a "loss of contact with reality". People suffering from psychosis are said to be ''psychotic.''

Drug may improve the safety of cannabis use in early pregnancy

Cannabis use during pregnancy may increase the risk of psychosis in children. Scientists have now found a drug that can reduce the effects of THC on the fetus.

16 Oct 2019

International system can provide practical guideline on cannabis use, say researchers

Despite widespread use of the drug around the world and increasing moves to legalise its sale for recreational consumption, standard units - which have been commonplace for alcohol for many years - have never been adopted in health guidelines for cannabis.

16 Oct 2019

New therapeutic approach for children born to mothers who used cannabis during pregnancy

As a growing number of U.S. states legalize the medicinal and recreational use of marijuana, an increasing number of American women are using cannabis before becoming pregnant and during early pregnancy often to treat morning sickness, anxiety, and lower back pain.

14 Oct 2019

Novel clinical trial to examine use of cannabidiol in people with Parkinson's-related psychosis

A pioneering clinical trial will investigate the use of cannabidiol (CBD) - a compound found in the cannabis plant - in people with Parkinson's-related psychosis.

14 Oct 2019

UC San Diego's CMCR announces research grants to explore cannabis for medical applications

The Center for Medicinal Cannabis Research (CMCR) at University of California San Diego School of Medicine, the nation's oldest research center for scientific inquiry into the safety and efficacy of cannabis, has announced $3 million in research grants to explore new applications of cannabis for a number of novel medical applications.

11 Oct 2019

Deficit schizophrenics are physically different from other people

The study, published in Schizophrenia Bulletin on August 19, 2019, points out some differences in mouth structure in people with one form of schizophrenia called deficit schizophrenia, compared with other schizophrenics and non-schizophrenics.

8 Oct 2019

Researchers find no evidence of adverse health outcomes linked with antidepressant use

Antidepressants are generally safe, according to a new study by an international team of researchers. By assessing evidence from 45 meta-analyses, which combined the results from many studies, the researchers did not find strong evidence of adverse health outcomes associated with antidepressant use.

2 Oct 2019

Cannabis: CBD vs THC causes lower psychiatric side-effects

A study has revealed how cannabidiol works against tetrahydrocannabinol to prevent psychiatric side effects.

1 Oct 2019

Veterans with mental health disorders have increased risk of heart attack, stroke

Veterans with specific mental health disorders - depression , psychosis and bipolar disorder - had an increased risk of heart attack, stroke and death from cardiovascular disease, according to new research published in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.

24 Sep 2019

Identification and management of depression in people with epilepsy to save lives

Depression is the most common psychiatric comorbidity in people with epilepsy. Clinical studies have found that 20% to 30% of people with epilepsy have depression; the incidence may be as high as 50% to 55% in people visiting hospital epilepsy centers.

21 Sep 2019

NIH awards research grants to develop learning health care system for early psychosis treatment

The National Institutes of Health awarded six research grants for studies to develop a learning health care system for the treatment of early psychosis.

20 Sep 2019

New uses for CBD in genetic brain disorder

A new study has revealed that cannabidiol can help people with a rare brain condition called Angelman syndrome to improve their behavioral traits and to control seizures.

19 Sep 2019

Neurological markers in the brain can help detect people at risk for psychotic disorders

Help may be on the way for people who might lose contact with reality through a psychotic disorder, such as schizophrenia.

27 Aug 2019

Study exposes major gaps in understanding the full burden of ADRD/dementia

A new research review highlighting the hidden costs of dementia suggests that traditional measures only show the ‘tip of the iceberg’ of the cost impact on society.

26 Aug 2019

Adolescents are using a highly potent form of marijuana, study finds

Nearly one in four Arizona teens have used a highly potent form of marijuana known as marijuana concentrate, according to a new study by Arizona State University researchers.

26 Aug 2019

Risk for schizophrenia and bipolar disorder has distinct effects on the brain

Brain abnormalities in people at familial risk of schizophrenia and bipolar disorder emerge in unique patterns, despite the symptom and genetic overlap of the disorders, according to a study in Biological Psychiatry, published by Elsevier.

20 Aug 2019

FDA approves effective new treatment for extremely drug-resistant tuberculosis

Tuberculosis is the leading infectious killer in the world, far above AIDS. It kills about 1.6 million of the 10 million it affects every year. About 30,000 patients worldwide now have XDR tuberculosis (that fails to respond to any of the four antibiotic categories in use at present).

15 Aug 2019

Breakthrough study identifies specific antibody target implicated in neuropsychiatric lupus

A breakthrough study by a SUNY Downstate Health Sciences University research team has identified a specific antibody target implicated in neuropsychiatric symptoms of lupus.

13 Aug 2019

Blood clotting proteins in urine act as potent biomarkers for lupus

The team of researchers at the University of Houston found that blood clotting proteins, both the ones that promote blood clotting (prothrombic) and those that disperse them (thrombolytic) are elevated in the urine of patients with lupus nephritis (LN).

7 Aug 2019

New study explores the effects of cannabis on brain neurochemistry

A new Addiction Biology study provides the first evidence of a blunted response to stress-induced dopamine signaling in the brain's prefrontal cortex in individuals at high risk for psychosis who regularly used cannabis.